Sangamo Therapeutics Direct Offering Aims to Raise $24M

Sangamo Therapeutics Raises Capital Through Direct Offering

Sangamo Therapeutics has initiated a securities purchase agreement in an attempt to raise $24M by selling shares and pre-funded warrants. The decision has led to a drop in the company's share value.

Key Points:

• Sangamo Therapeutics is seeking to boost its capital through the offering.
• Investors' reaction to the news has resulted in a decline in share prices.